Finally, this work was primarily performed in the VCaP cell line, which contains wild-type full-length AR and demonstrates a unique responsiveness to both DHT and MDV compared to other prostate cancer cell lines [5, 6]. The gene discussed is AR; the disease is prostate carcinoma.